Skip to main content
. 2018 Oct 15;69(2):207–214. doi: 10.1093/cid/ciy881

Figure 2.

Figure 2.

Prevalence of any pretreatment drug resistance and nonnucleoside reverse transcriptase inhibitor resistance among 1148 participants with next-generation sequencing data detected at 5% and 20% detection thresholds. Abbreviations: NNRTI, nonnucleoside reverse transcriptase inhibitor; PDR, pretreatment drug resistance.